Truth in Medicine

Money in Medicine

The claim

“Doctors are the reason healthcare is so expensive. They're in it for the money.”

The short answer

Doctors' own earnings are about 8.6% of US health spending. American doctors are paid more than doctors abroad, and that is part of the bill, but the bigger drivers are hospital prices, drug prices and administration. Where the claim does land is on incentives: how doctors are paid, who owns their practices and who buys them lunch measurably changes the care patients get.

Are doctors why US healthcare costs so much? They take about 9 cents of every dollar, and influence far more.

The US spent $5.3 trillion on healthcare in 2024. Here's how much of it actually reaches doctors, who really sets the prices, and where money genuinely shapes the care you get.

Why the claim feels right

It isn't hard to see where this belief comes from.

Doctors are the face of the system. They order the tests, write the prescriptions and recommend the surgery. Their names are on the bill. Doctors are among the best-paid people in the country, and Americans pay more for healthcare than anyone else on earth. Put those facts side by side and "doctors are the reason it's so expensive" sounds like common sense.

There's real substance underneath it, too. As you'll see, American doctors are paid more than doctors in other rich countries, and the way doctors are paid does change how much care gets delivered.

But "the reason" is a strong claim. To test it, you have to follow the money.

Where the $5.3 trillion goes

In 2024 the US spent $5.3 trillion on healthcare: $15,474 per person, or 18% of the whole economy. That's according to the government's own accounting, the National Health Expenditure data kept by the Centers for Medicare & Medicaid Services (CMS).

The biggest pieces:

  • Hospital care: $1.63 trillion, close to a third of the total.
  • Physician and clinical services: $1.11 trillion, about a fifth.
  • Prescription drugs: $467 billion, a little under a tenth.

That middle number looks like it settles the question: a fifth of all spending goes to doctors. It doesn't. That category is everything paid for care in doctors' offices and clinics of every kind. Out of it, practices pay nurses, receptionists, billing staff, rent, equipment and malpractice insurance, and many of the clinicians it pays aren't physicians at all.

So how much actually ends up in doctors' pockets?

How much reaches doctors

The best answer comes from a team of economists led by Joshua Gottlieb at the University of Chicago and Maria Polyakova at Stanford. Instead of relying on surveys, they linked the national registry of US physicians to their tax records and Medicare billing data, covering nearly every doctor in the country.

Their finding: physicians' earnings average about $350,000 a year and add up to 8.6% of national health spending.

That's about 9 cents of every healthcare dollar. Even if every American doctor took a 20% pay cut tomorrow, total health spending would fall by less than 2%.

That doesn't let doctors off the hook completely. The same researchers found that when Medicare raises its fees, about a quarter of the extra fee revenue ends up in doctors' personal earnings. And a landmark 2018 comparison in JAMA found that American physicians really are paid more than their peers abroad. In that analysis, a US generalist physician earned $218,173, against $86,607 to $154,126 in ten other high-income countries.

But that same JAMA study points to where the big money goes. The US spent roughly twice as much as the other countries, yet Americans used largely similar amounts of care: similar rates of hospital admissions, hip and knee replacements and heart bypass surgery. Imaging was the exception, with more MRI and CT scans. The difference was prices: of labour, of drugs, and of administration. Administrative costs alone took 8% of US health spending, against 1% to 3% elsewhere. Pharmaceutical spending was $1,443 per person, against $466 to $939.

Doctors' pay is part of the American price problem. It's not most of it.

What doctors earn, and what it costs to get there

I've written about whether doctors are rich in a separate article, so here's the short version.

The government puts the median US physician at $275,930 a year. By specialty, medians range from about $210,000 for general pediatricians and $244,000 for family doctors to $496,000 for cardiologists and $559,000 for pediatric surgeons. Emergency physicians like me sit around $336,000.

That income arrives late. After medical school, most new doctors spend 3 to 7 years in residency, according to the AAMC. The AAMC reports that the median medical school debt for the class of 2024 was $205,000, and that four years of medical school for the class of 2025 cost a median of about $286,000 at a public school and $391,000 at a private one.

None of that makes high pay wrong or right. It's simply the context: a large salary at the end of a long, expensive pipeline, and a pipeline that the Gottlieb team argues is deliberately narrow. Their paper concludes that physician earnings reflect "policy choices to subsidize demand for physician care, amplified by restrictions on physician entry."

Who actually sets the prices

Here's what most people don't realise: most doctors don't set their own prices. Not in any way that matters.

Medicare pays according to a government fee schedule covering thousands of services. But doctors have a powerful hand in it. CMS decides how much work each service involves with advice from the AMA/Specialty Society RVS Update Committee, known as the RUC: a committee the American Medical Association set up, representing national physician organisations. CMS makes the final call. A study in Health Affairs found that between 1994 and 2010, CMS agreed with 87.4% of that committee's recommendations. Some primary-care experts have blamed the committee for widening the pay gap between specialists and family doctors. And because Medicare's fees influence what other public and private insurers pay, those decisions ripple across the whole market.

Private insurers negotiate their prices, and here the bigger number belongs to hospitals. RAND tracked actual claims paid by employers and private plans. In 2022, they paid hospitals 254% of what Medicare would have paid for the same services at the same hospitals. Hospital outpatient care ran at 279% of Medicare. Professional services, the doctors' side of those bills, ran at 184%.

Doctors' fees from private plans are rising too. The Medicare Payment Advisory Commission (MedPAC), Congress's independent advisers, found that in 2024 private PPO plans paid clinicians 147% of Medicare rates, up from 140% the year before. MedPAC links part of that to practices consolidating into larger groups to win better rates from insurers.

And fewer doctors control their own businesses at all. The AMA's surveys show that the share of physicians in private practice fell from 60.1% in 2012 to 42.2% in 2024. About a third (34.5%) now work in practices owned by hospitals. When a hospital system owns the practice, it, not the doctor, negotiates the prices.

Has Medicare pay kept up?

This is where doctors and their critics talk past each other, so let's take both sides seriously.

The doctors' case. The AMA calculates that, adjusted for inflation in the cost of running a practice, Medicare physician payment fell 33% between 2001 and 2025. As the AMA points out, hospitals get an annual Medicare rate change tied to inflation; the physician fee schedule doesn't. In 2027, current law calls for Medicare's physician rates to fall by 1.7% to 2.2%, after a temporary one-year 2.5% boost expires. Remember that the AMA is a physicians' lobby, so this is advocacy analysis. But the basic point, that updates have lagged practice costs, isn't disputed.

The counter-case. MedPAC agrees the updates have lagged. But it also points out that the volume and intensity of services per patient have risen substantially, so total Medicare spending on doctors has kept growing. In 2024, spending on clinician services per traditional Medicare patient grew 4.1%, even though payment rates for many services fell. MedPAC's 2025 survey found Medicare patients reported access to doctors that was generally better than people with private insurance. And according to compensation data MedPAC cites, median physician pay rose 6% to $369,000 in 2024, twice the rate of inflation.

MedPAC's conclusion: below-inflation updates haven't yet hurt access, but costs that keep outrunning payment could become hard to absorb. It recommended a small increase above current law for 2027.

Both things are true. Medicare pays doctors less per service, in real terms, than it did a generation ago. And doctors are, on the whole, doing more services and earning well.

Where money genuinely shapes care

This is the part of the claim that deserves to be taken most seriously. Doctors are human, and incentives work on humans. The evidence is clear that they do.

Fee-for-service rewards doing more

Much of American medicine is still paid per service, known as fee-for-service: each visit, test and procedure is billed separately. Medicare's physician fee schedule alone sets prices for about 9,000 types of service. That system rewards volume.

The cleanest evidence comes from a natural experiment. In 1997 Medicare reorganised the regions it uses to adjust its fees, raising payments in some areas and cutting them in others, for reasons unrelated to local patients. Economists Jeffrey Clemens and Joshua Gottlieb found that every 2% rise in payment rates led to about a 3% rise in care delivered. Elective procedures such as cataract surgery responded most strongly. Non-radiologists bought into MRI. And the extra care produced only "economically small" health gains, though the estimate was imprecise.

In plain terms: when you pay more for something, doctors do more of it, and the extra isn't always the care patients needed most.

Private equity changes the math

Private equity firms buy medical practices and hospitals as investments. Two large studies show what can follow.

When private equity bought dermatology, gastroenterology and ophthalmology practices between 2016 and 2020, the practices' charges per claim rose 20.2% and the amount actually paid per claim rose 11%, compared with similar practices that weren't bought. They saw more new patients, and the share of established-patient office visits billed as longer than 30 minutes rose 9.4%.

In hospitals, the findings were about patient safety. A JAMA study compared 51 hospitals bought by private equity with 259 similar hospitals that weren't, using Medicare records from 2009 to 2019. After acquisition, Medicare patients at the private-equity hospitals had a 25.4% increase in hospital-acquired complications, including 27% more falls and 38% more central-line bloodstream infections, even though those hospitals placed fewer central lines.

These are associations, not proof of cause. But they're consistent, and they come from careful studies. Private equity owned the practices of 6.5% of physicians in 2024, according to the AMA, up from 4.5% in 2022.

Drug and device companies pay doctors

Since 2013, a federal programme called Open Payments has required drug and device makers to report what they pay doctors and teaching hospitals. You can look up any doctor by name.

For 2025, companies reported $14.67 billion across 17 million records. Most of that, $9.5 billion, was research funding. But $3.92 billion was general payments, such as consulting fees, speaking fees, travel and meals, and another $1.25 billion was ownership or investment interests. 667,898 physicians had at least one payment recorded.

Does a payment change what a doctor does? Even small ones are associated with it. A study in JAMA Internal Medicine looked at Medicare prescribing by nearly 280,000 doctors. Physicians who received a single industry-sponsored meal, typically worth less than $20, were more likely to prescribe the brand-name drug being promoted over cheaper alternatives in the same class. For one antidepressant, the odds were more than double. More meals, and pricier meals, were linked to more prescribing.

That study can't prove the meal caused the prescription; doctors who already like a drug may be more likely to accept lunch from its maker. But it fits everything else we know about marketing. Companies don't spend billions on doctors for nothing.

As a physician, I'd rather patients knew this than didn't. It's fair to look up your own doctor on Open Payments, and it's fair to ask why a brand-name drug was chosen when a generic exists.

So who is to blame?

If you're angry about what American healthcare costs, the evidence says you're right to be. But the main drivers are prices, set through hospital market power, drug pricing and administrative complexity, more than the number of doctors or the amount of care they deliver.

Doctors are part of that story in three ways:

  1. Their pay is high by international standards, and a share of every fee increase reaches them.
  2. Organised medicine has real influence over how Medicare values services, and critics argue it has favoured specialists over primary care.
  3. Incentives shape their decisions, through fee-for-service volume, corporate and private-equity ownership, and industry money.

What doctors mostly don't do is set the prices you see on a hospital bill.

The bottom line

Doctors earn about 8.6% of US health spending. Paying them less would trim the bill, but it wouldn't close the gap with other rich countries, which comes mainly from higher prices for hospital care, drugs and administration.

"In it for the money" isn't fair to the profession as a whole. But it isn't baseless either. The evidence shows that how doctors are paid, who owns their practices and what drug companies give them all change the care patients receive. The honest fix isn't to vilify doctors. It's to change the incentives, and to make them visible.

This is general education, not personal financial or medical advice.

Sources

  1. Centers for Medicare & Medicaid Services. National Health Expenditure Fact Sheet (historical data for 2024 and projections 2025–2034).
  2. Gottlieb JD, Polyakova M, Rinz K, Shiplett H, Udalova V. The Earnings and Labor Supply of U.S. Physicians. Working paper, December 2024 (NBER Working Paper 31469).
  3. Papanicolas I, Woskie LR, Jha AK. Health care spending in the United States and other high-income countries. JAMA. 2018;319(10):1024–1039.
  4. US Bureau of Labor Statistics. Occupational Outlook Handbook: Physicians and Surgeons (May 2025 wage data).
  5. Balch B. Proposed changes to federal student loans could worsen doctor shortage. AAMCNews, 25 June 2025.
  6. Association of American Medical Colleges. Medical School Class of 2025: Their Journey into a Career in Medicine. 2025.
  7. American Medical Association. AMA/Specialty Society RVS Update Committee (RUC).
  8. Laugesen MJ, Wada R, Chen EM. In setting doctors' Medicare fees, CMS almost always accepts the relative value update panel's advice on work values. Health Aff (Millwood). 2012;31(5):965–972.
  9. Whaley CM, Kerber R, Wang D, Kofner A, Briscombe B. Prices Paid to Hospitals by Private Health Plans: Findings from Round 5.1 of an Employer-Led Transparency Initiative. RAND Health Quarterly. 2025;12(2):5.
  10. Medicare Payment Advisory Commission. Report to the Congress: Medicare Payment Policy, Chapter 4: Physician and other health professional services. March 2026.
  11. Henry TA. Medicare physician pay has plummeted since 2001. Find out why. AMA News Wire, 21 April 2025.
  12. American Medical Association. Medicare updates compared to inflation in practice costs (2001–2025). January 2025.
  13. American Medical Association. Smaller share of doctors in private practice than ever before. 24 June 2025.
  14. Clemens J, Gottlieb JD. Do physicians' financial incentives affect medical treatment and patient health? Am Econ Rev. 2014;104(4):1320–1349.
  15. Singh Y, Song Z, Polsky D, Bruch JD, Zhu JM. Association of private equity acquisition of physician practices with changes in health care spending and utilization. JAMA Health Forum. 2022;3(9):e222886.
  16. Kannan S, Bruch JD, Song Z. Changes in hospital adverse events and patient outcomes associated with private equity acquisition. JAMA. 2023;330(24):2365–2375.
  17. Centers for Medicare & Medicaid Services. Open Payments: Data Overview (Program Year 2025 data, published 2026).
  18. DeJong C, Aguilar T, Tseng CW, Lin GA, Boscardin WJ, Dudley RA. Pharmaceutical industry–sponsored meals and physician prescribing patterns for Medicare beneficiaries. JAMA Intern Med. 2016;176(8):1114–1122.

Found this useful? Pass it on.

← All posts